Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior

International Journal of Developmental Neuroscience

Volumn 26, Issue 5, 2008, Pages 423-434

  Lim, Maria A ^a   Stack, Conor M ^a   Cuasay, Katrina ^a   Stone, Madeleine M ^a   McFarlane, Hewlet G ^a,b   Waschek, James A ^c   Hill, Joanna M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b KENYON COLLEGE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Developmental delays; Developmental milestones; Maternal attachment; Neurodevelopmental disorders; Neuropeptide; Play behavior; Social behavior; Vasoactive intestinal peptide

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; GENOTYPE; GROWTH DISORDER; MALE; MATERNAL BEHAVIOR; MATING; MOUSE; NONHUMAN; PLAY; POST HOC ANALYSIS; PRIORITY JOURNAL; PROGENY; SOCIOPATHY; WEIGHT GAIN; WILD TYPE;

ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; FEMALE; GENOTYPE; MALE; MICE; MICE, KNOCKOUT; SOCIAL BEHAVIOR; VASOACTIVE INTESTINAL PEPTIDE;

MUS;

EID: 43049181746     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2008.03.002     Document Type: Article

References (61)

1. Anton S.J., Colwell C.S., Harmar A.J., Waschek J.A., and Herzog E.D. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat. Neurosci. 8 (2005) 476-483
2. Baker J., Liu J.-P., Robertson E.J., and Efstratiadis A. Role of insulin like growth factors in embryonic and postnatal growth. Cell 75 (1993) 73-82
3. Bartolomucci A., Gioiosa L., Chirieleison A., Ceresini G., Parmigiani S., and Palanza P. Cross-fostering in mice: behavioral and physiological carry-over effects in adulthood. Genes Brain Behav. 3 (2004) 115-122
4. Bassan M., Zamostiano R., Davidson A., Pinhasov A., Giladi E., Perl O., Bassan H., Blat C., Gibney G., Glazner G., Brenneman D.E., and Gozes I. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72 (1999) 1283-1293
5. Brenneman D.E., Hauser J., Spong C.Y., and Phillips T.W. VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death. Brain Res. 838 (1999) 27-36
6. Brenneman D.E., Hauser J.M., Spong C.Y., and Phillips T.M. Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity. Neuropeptides 36 (2002) 271-280
7. Brenneman D.E., Hill J.M., Glazner G.W., Gozes I., and Phillips T.W. Interleukin-1 alpha and vasoactive intestinal peptide: enigmatic regulation of neuronal survival. J. Dev. Neurosci. 13 (1995) 187-200
8. Brenneman D.E., Nicol T., Warren D., and Bowers L.M. Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25 (1990) 386-394
9. Brown R.E., Mathieson W.B., Stapleton J., and Neumann P.E. Maternal behavior in female C57BL/6J and DBA/2J inbred mice. Physiol. Behav. 67 (1999) 599-605
10. Colwell C.S., Michel S., Itri J., Rodriguez W., Tam J., Lelieve V., Hu Z., Liu X., and Waschek J.A. Disrupted circadian rhythms in VIP- and PHI-deficient mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 258 (2003) R939-R949
11. Colwell C.S., Michel S., Itri J., Rodriguez W., Tam J., Lelievre V., Hu Z., Liu X., and Waschek J.A. Selective deficits in the circadian light response in mice lacking PACAP. Am. J. Physiol. Regl. Integr. Comp. Physiol. 287 (2004) R1194-R1201
12. Dibbern D.A., Glazner G.W., Gozes I., Brenneman D.E., and Hill J.M. Inhibition of murine embryonic growth by human immunodeficiency virus envelope protein and its prevention by vasoactive intestinal peptide and activity-dependent neurotrophic factor. J. Clin. Invest. 99 (1997) 2837-2841
13. Dyer D.P., and Southwick C.H. A possible sensitive period for juvenile socialization in mice. Behav. Biol. 12 (1974) 551-558
14. Falluel-Morel A., Vaudry D., Aubert N., Galas L., Benard M., Basille M., Fontaine M., Fournier A., Vaudry H., and Gonzalez B.J. Pituitary adenylate cyclase-activating polypeptide prevents the effects of ceramides on migration, neurite outgrowth, and cytoskeleton remodeling. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2637-2642
15. Giladi E., Hill J.M., Dresner E., Stack C.M., and Gozes I. Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo. J. Mol. Neurosci. 33 (2007) 278-283
16. Girard B.A., Lelievre V., Braas K.M., Razinia T., Vizzard M.A., Ioffe Y., El Meskini R., Ronnett G.V., Waschek J.A., and May V. Noncompensation in peptide/receptor gene expression and distinct behavioral phenotypes in VIP- and PACAP-deficient mice. J. Neurochem. 99 (2006) 499-513
17. Glazner G.W., Gressens P., Lee S.J., Gibney G., Gozes I., Gozes Y., Brenneman D.E., and Hill J.M. Activity-dependent neurotrophic factor: A potent regulator of embryonic growth. Anat. Embryol. 200 (1999) 65-71
18. Gozes I., Glowa J., Brenneman D.E., McCune S.K., Lee E., and Westphal H. Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene. J. Mol. Neurosci. 4 (1993) 185-193
19. Gozes I., Lilling G., Glazer R., Ticher A., Ashkenazi I.E., Davidson A., Rubenraut S., Fridkin M., and Brenneman D.E. Superactive lipophilic peptides discriminate multiple vasoactive intestinal peptide receptors. J. Pharmacol. Exp. Ther. 273 (1995) 161-167
20. Gozes I., Meltzer E., Rubinrout S., Brenneman D.E., and Fridkin M. Vasoactive intestinal peptide potentiates sexual behavior: inhibition by novel antagonist. Endocrinology 125 (1989) 2945-2949
21. Gozes I., Schachter P., Shani Y., and Giladie Y. Vasoactive intestinal peptide gene expression from embryos to aging rats. Neuroendocrinology 47 (1988) 27-31
22. Grant E.C., and Mackintosh J.H. A comparison of social postures of some common laboratory rodents. Behavior 21 (1963) 246-259
23. Gressens P., Hill J.M., Gozes I., Fridkin M., and Brenneman D.E. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 362 (1993) 155-158
24. Gressens P., Hill J.M., Paindaveine P., Gozes I., Fridkin M., and Brenneman D.E. Severe microcephaly induced by blockade of vasoactive intestinal peptide function in the primitive neuroepithelium of the mouse. J. Clin. Invest. 94 (1994) 2020-2027
25. Heap R.B., Taussig M.J., Wang M.W., and Whyte A. Antibodies, implantation and embryo survival. Reprod. Fertil. Dev. 4 (1992) 467-480
26. Hill J.M. Vasoactive intestinal peptide in neurodevelopmental disorders: Therapeutic potential. Curr. Pharmaceut. Des. 13 (2007) 1079-1089
27. Hill J.M., Ades A.M., McCune S.K., Sahir N., Moody E.M., Abebe D.T., Crnic L.S., and Brenneman D.E. Vasoactive intestinal peptide in the brain of a mouse model for Down syndrome. Exper. Neurol. 183 (2003) 56-65
28. Hill J.M., Cuasay K., and Abebe D.T. Vasoactive intestinal peptide antagonist treatment during mouse embryogenesis impairs social behavior and cognitive function of adult male offspring. Exp. Neurol. 206 (2007) 101-113
29. Hill J.M., Gozes I., Hill J.M., Fridkin M., and Brenneman D.E. Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat. Peptides 12 (1991) 187-192
30. Hill J.M., Hauser J.M., Sheppard L.M., Abebe D.T., Spivak-Pohis I., Kushnir M., Deitch I., and Gozes I. Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry. J. Mol. Neurosci. 31 (2007) 183-200
31. Hill J.M., Lee S.J., Dibbern D.A., Fridkin M., Gozes I., and Brenneman D.E. Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth. Neuroscience 93 (1999) 783-791
32. Hill J.M., Lim M.A., and Stone M.M. Developmental milestones in the newborn mouse. In: Gozes I. (Ed). Neuropeptide Techniques (2008), Humana Press, Totowa, NJ 131-149
33. Hill J.M., McCune S.K., Alvero R.J., Glazner G.W., Henins K.A., Stanziale S.F., Keimowitz J.R., and Brenneman D.E. Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent. J. Clin. Invest. 97 (1996) 202-208
34. Hill J.M., Mehnert J., McCune S.K., and Brenneman D.E. Vasoactive intestinal peptide regulation of nerve growth factor in the embryonic mouse. Peptides 23 (2002) 1803-1808
35. Hill J.M., Mervis R.F., Politi J., McCune S.K., Gozes I., Fridkin M., and Brenneman D.E. Blockade of VIP during neonatal development induces neuronal damage and increases VIP and VIP receptors in brain. Ann. N. Y. Acad. Sci. 739 (1994) 211-225
36. Iwasaki Y., Ikeda K., Ichikawa Y., and Igarashi O. Vasoactive intestinal peptide influences neurite outgrowth in cultured rat spinal cord neurons. Neurol. Res. 23 (2001) 851-854
37. Jessell T.M., and Dodd J. Floor plate-derived signals and the control of neural cell pattern in vertebrates. Harvey Lectures Ser. 86 (1992) 87-128
38. Jin S.-H., Blendy J.A., and Thomas S.A. Cyclic AMP response element-binding protein is required for normal maternal nurturing behavior. Neuroscience 133 (2005) 647-655
39. Liu J.-P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor-1 (IGF-1) and type-1 IGF receptor (IGF-1R). Cell 75 (1993) 59-72
40. Lu N.R., Black I.B., and DiCicco-Bloom E. A paradigm for distinguishing the roles of mitogenesis and trophism in neuronal precursor proliferation. Dev. Brain Res. 94 (1996) 31-36
41. Moles A., Kieffer B.L., and D'Amato F.R. Deficit in attachment behavior in mice lacking the mu-opioid receptor. Science 304 (2004) 1888-1889
42. Nelson K.B., Grether J.K., Croen L.A., Dambrosia J.M., Dickens B.F., Hansen R.L., and Phillips T.M. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol. 49 (2001) 597-606
43. Nicot A., Lelievre V., Tam J., Waschek J.A., and DiCicco-Bloom E. Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation. J. Neurosci. 22 (2002) 9244-9254
44. Pincus D.W., DiCicco-Bloom E.M., and Black I.B. Vasoactive intestinal peptide regulation of neuroblast mitosis and survival: Role of cAMP. Brain Res. 514 (1990) 355-357
45. Pincus D.W., DiCicco-Bloom E.M., and Black I.B. Trophic mechanisms regulate mitotic neuronal precursors: role of vasoactive intestinal peptide (VIP). Brain Res. 663 (1994) 51-60
46. Pinhasov A., Mandel S., Torchinsky A., Giladi E., Pittel Z., Goldsweig A.M., Servoss S.J., Brenneman D.E., and Gozes I. Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res. Dev. Brain Res. 144 (2003) 83-90
47. Powell-Braxton L., Hollingshead P., Warburton C., Dowd M., Pitts-Mee S., Dalton D., Gillett N., and Stewart T.A. IGF-1 is required for normal embryonic growth in mice. Genes Dev. 7 (1993) 2609-2617
48. Sahir N., Brenneman D.E., and Hill J.M. Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation. J. Mol. Neurosci. 30 (2006) 81-92
49. Servoss S.J., Lee S.J., Gibney G., Brenneman D.E., and Hill J.M. Insulin-like growth factor-I as a mediator of vasoactive intestinal peptide/activity-dependent neurotrophic factor-stimulated embryonic growth. Endocrinology 142 (2001) 3348-3353
50. Shuto Y., Uchida D., Onda H., and Arimura A. Ontogeny of pituitary adenylate cyclase activating polypeptide and its receptor mRNA in the mouse brain. Regul. Pept. 67 (1996) 70-83
51. Spong C.Y., Lee S.J., McCune S.K., Gibney G., Abebe T.D., Alvero R., Brenneman D.E., and Hill J.M. Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology 140 (1999) 917-924
52. Szema A.M., Hamidi S.A., Lyubsky S., Dickman K.G., Mathew S., Abdel-Razek T., Chen J.J., Waschek J.A., and Said S.I. Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP. Am. J. Physiol. Lung Cell. Mol. Physiol. 291 (2005) L880-L886
53. Terranova M.L., and Laviola G. Scoring of social interactions and play in mice during adolescence. Curr. Protocols Toxicol. 13 (2005) 10.1-10.10
54. Terranova M.L., Laviola G., and Alleva E. Ontogeny of amicable social behavior in the mouse: Gender differences and ongoing isolation outcomes. Dev. Psychobiol. 26 (1993) 467-481
55. Terranova M.L., Laviola G., de Acetis L., and Alleva E. A description of the ontogeny of mouse agonistic behavior. J. Comp. Psychol. 112 (1998) 3-12
56. Venerosi A., Valanzano A., Alleva E., and Calamandrei G. Prenatal exposure to anti-HIV drugs: neurobehavioral effects of zidovudine (AZT) plus lamivudine (3TC) treatment in mice. Teratology 63 (2001) 26-37
57. Waschek J.A. Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev. Neurosci. 24 (2002) 14-23
58. Waschek J.A., Elloison J., Bravo D.T., and Handley V. Embryonic expression of vasoactive intestinal peptide (VIP) and VIP receptor genes. Neurochemistry 66 (1996) 1762-1767
59. Wilcox A.J., Weinberg C.R., O'Connor J.F., Baird D.D., Schlatterer J.P., Canfield R.E., Armstrong E.G., and Nisula B.C. Incidence of early loss of pregnancy. New Engl. J. Med. 319 (1988) 189-194
60. Williams E., and Scott J.P. The development of social behaviour patterns in the mouse, in relation to natural periods. Behaviour 6 (1953) 35-65
61. Wu J., Henins K.A., Gressens P., Gozes I., Fridkin M., Brenneman D.E., and Hill J.M. Prenatal blockage of vasoactive intestinal peptide delays developmental milestones in the neonatal mouse. Peptides 18 (1997) 1131-1137